A large biopharmaceutical company sought to boost learning and development for marketing and sales in order to create a high performing, continuous learning culture. Learn how Vynamic leveraged its experience in strategic planning, change management, and culture curation to deliver tailored Sales & Marketing Excellence programs that improved employee engagement, and built key skills, knowledge, and behaviors.
A large biopharmaceutical company sought to boost learning and development for marketing and sales in order to create a high performing, continuous learning culture. Learn how Vynamic leveraged its experience in strategic planning, change management, and culture curation to deliver tailored Sales & Marketing Excellence programs that improved employee engagement, and built key skills, knowledge, and behaviors.
The analytics, data, and insights function of a large global pharmaceutical company experienced several substantial changes in a short timeframe. Learn how Vynamic helped reposition this remodeled function as a strategic partner to internal stakeholders through a robust communications toolkit that conveyed their new identity, value, and offerings in a compelling way.
A second-in-portfolio pharmaceutical product faced underperformance during their critical launch window and asked Vynamic to conduct a 360° assessment of brand strategy and tactical execution.
To meet evolving HCP expectations and our Life Sciences client’s business objectives, Vynamic collaboratively developed a new customer-centric omnichannel ecosystem that would transform how the brand (and the company) approached marketing.
A regional health plan sought to migrate to a new CRM platform as part of a multi-year technology transformation aimed at better servicing its members. This CRM is used by roughly a third of the client’s employees to document and manage tens of thousands of customer interactions a year.
A Global Medical Affairs infectious disease team wanted to understand and leverage key learnings from Disease Awareness pre-launch/launch activities of relevant analog vaccines to inform a global strategy for a vaccine in clinical development. Learn more about how Vynamic approached and delivered this project.
The COVID-19 pandemic has changed how new therapies are commercially launched in the US, and many life sciences manufacturers have had to pivot to ensure patients are able to access medications they need. Learn how Vynamic recently advised two large pharmaceutical companies working within in an alliance on how to pivot their launch planning efforts (both internally and externally) for two oncology indication launches.
The Global Vaccines team of a large pharmaceutical company engaged Vynamic to provide a strategic assessment of the potential impact of COVID-19 on the future landscape of diagnostics and surveillance of respiratory viruses.
It's no secret that many health systems and health system leaders are always looking for ways to innovate and become more efficient, and one way to do that is through Lean Methodology. The challenge is, many times the idea of Lean and the methodology behind it are very hard to implement. Vynamic was approached by a long-standing client, a large statewide integrated delivery network, with this precise problem.
Contact our team to learn more about how we can help your needs.
